Journey Medical Corporation Quarterly report pursuant to Section 13 or 15(d)

INTEREST EXPENSE AND FINANCING FEES

3 Months Ended

Mar. 31, 2022

NOTE 14. INTEREST EXPENSE AND FINANCING FEES

Interest expense and financing fees for the periods consisted of the following:


	Three-month periods ended March 31,
	2022						2021
($'s in thousands)	Interest		Fees¹		Total		Interest		Fees¹		Total
Interest payments for EWB term loan	$	161	$	—	$	161	$	—	$	—	$	—
Amortiztion of term loan costs		—		14		14		—		—		—
Amortiztion of line of credit costs		—		11		11		—		—		—
Installment payments - licenses ²		148		—		148		221		—		221
Accretion of deferred payment		55		—		55		—		—		—
Total Interest Expense and Financing Fee	$	364	$	25	$	389	$	221	$	—	$	221

Note 1: Amortization of fees in connection with the Amended EWB Agreement.

Note 2: Imputed interest expense related to acquired intangible assets.